Access over 20 million homework & study documents

miniossayschicken101 Nursing 329 Week 7 ala medication

Content type
User Generated
School
chamberlain university
Rating
Showing Page:
1/1
© 2021 Chamberlain University. All Rights Reserved
Medication Name and Type
Gloperba (Antimitotic)
Drug Class
Antigout Agents
Expected Pharmacological Mechanism of
Action (How it Works)
Interferes with the capabilities of WBCs in
starting up and perpetuating the
inflammatory reaction to monosodium
urate crystals.
Therapeutic Uses (Indications)
It helps to treat acute attacks of gouty
arthritis. Prophylaxis.
Contraindications
Contraindicated in hypersensitivity; Could
lead to renal and hepatic impairment. Use
of P-glycoprotein inhibitors or strong
CYP3A4 inhibitors in patients with renal or
hepatic impairment.
Complications
Derm: alopecia. Gi: diarrhea, nausea,
vomiting, abdominal pain. Hemat:
agranulocytosis, aplastic anemia,
leukopenia, thrombocytopenia. Neuro:
peripheral neuritis.
Interactions
Drug-Drug: Concurrent use of strong
CYP3A4 inhibitors, including atazanavir,
clarithromycin, etc. and risk of toxicity;
colchicine dose in patients with normal
renal or hepatic function; concurrent use in
patients with renal or hepatic impairment
is contraindicated.
Medication Administration (Dose and
Route)
PO (Adults): 1.2 mg initially, then 0.6 mg 1
hr later (maximum dose of 1.8 mg in 1 hr);
Nursing Interventions
Monitor intake and output ratios. Fluids
should be encouraged to promote a urinary
output of at least 2000 mL/day.
Client Education
Instruct patient to take colchicine as
directed. Review medication administration
schedule. Take missed doses as soon as
remembered unless almost time for next
dose.
Evaluation of Medication Effectiveness
Decrease in pain and swelling in affected joints
within 12 hr. Relief of symptoms within 24 48
hr. Prevention of acute gout attacks. Reduced
number of attacks of familial Mediterranean
fever.

Sign up to view the full document!

lock_open Sign Up
Unformatted Attachment Preview
Expected Pharmacological Mechanism of Action (How it Works) Contraindications Contraindicated in hypersensitivity; Could lead to renal and hepatic impairment. Use of P-glycoprotein inhibitors or strong CYP3A4 inhibitors in patients with renal or hepatic impairment. Interferes with the capabilities ...
Purchase document to see full attachment
User generated content is uploaded by users for the purposes of learning and should be used following Studypool's honor code & terms of service.

Anonymous
Really helpful material, saved me a great deal of time.

Studypool
4.7
Trustpilot
4.5
Sitejabber
4.4